Efficacy of a Depigmented Extract of Phleum in Local Allergic Rhinitis
NCT02126111 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 56
Last updated 2016-11-08
Summary
The purpose of this study is evaluate the efficacy of a depigmented grass extract in the treatment of local allergic rhinitis.
Conditions
- Allergic Rhinitis
Interventions
- BIOLOGICAL
-
DEPIGOID phleum
Subcutaneous Immunotherapy with modified extract of Phleum pollen.
- BIOLOGICAL
-
DEPIGOID Placebo
Placebo for subcutaneous administration
Sponsors & Collaborators
-
Laboratorios Leti, S.L.
collaborator INDUSTRY -
Plaza del Hospital Civil
lead OTHER
Principal Investigators
-
Miguel Blanca, MD, PhD · Hospital Regional Universitario, Málaga, Spain
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-10-31
- Primary Completion
- 2016-04-30
- Completion
- 2016-04-30
Countries
- Spain
Study Locations
More Related Trials
-
Subcutaneous Immunotherapy With Dermatophagoides Pteronyssinus in Local Allergic Rhinitis
NCT02123316 ·Status: COMPLETED ·Phase: PHASE2
-
Determination of Biological Activity of Three Allergen Extracts
NCT02474836 ·Status: COMPLETED ·Phase: PHASE2
-
Biological Standardization of Dactylis Glomerata Allergen Extract
NCT01407835 ·Status: COMPLETED ·Phase: PHASE2
-
Biological Standardization of Dermatophagoides Pteronyssinus Allergen Extract
NCT01821716 ·Status: COMPLETED ·Phase: PHASE2
-
Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Grass Pollen
NCT00916422 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma
NCT02340130 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract
NCT05641272 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma
NCT00671268 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect Of PF-03654764 +/- Allegra On Symptoms Of Allergic Rhinitis
NCT01033396 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of PG102, a Water Soluble Extract From Actinidia Arguta, on Serum Total IgE Levels
NCT01106703 ·Status: COMPLETED ·Phase: PHASE2
-
Subcutaneous-Sublingual Immunotherapy With Depigmented and Polymerized Dermatophagoides Pteronyssinus Allergen Extract
NCT00622362 ·Status: TERMINATED ·Phase: PHASE2
-
Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens
NCT00666341 ·Status: COMPLETED ·Phase: PHASE2
-
Biological Standardization of D. Glomerata, L. Perenne, S. Cereale and O. Europaea Pollen Extracts
NCT01567319 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Clinical Trial With Depigopid 50% Grasses/50% Olea Europaea(2000DPP/ml) or Depigoid 50% Grasses/50% Parietaria Judaica(2000DPP/ml).
NCT01734265 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Test a New Decongestant in Patients With Allergic Rhinitis Following a Nasal Allergen Challenge
NCT00562120 ·Status: COMPLETED ·Phase: PHASE2
-
Biological Standardization of Poa Pratensis Allergen Extract
NCT01430117 ·Status: COMPLETED ·Phase: PHASE2
-
Biological Standardization of Platanus Acerifolia Allergen Extract
NCT01739322 ·Status: COMPLETED ·Phase: PHASE2
-
Allergic Inflammation in Rhinitis Patients Following Nasal Allergen Challenge
NCT01657097 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Lectranal® in Treatment of Seasonal Allergic Rhinitis Symptoms
NCT00460538 ·Status: COMPLETED ·Phase: PHASE4
-
Dose Finding Study for Depigoid Birch: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma
NCT01144429 ·Status: COMPLETED ·Phase: PHASE2
-
Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract
NCT05297760 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety Study of Olopatadine Nasal Spray
NCT00578331 ·Status: COMPLETED ·Phase: PHASE3
-
Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and Asthma
NCT00135642 ·Status: COMPLETED ·Phase: PHASE3
-
Documentation of Efficacy of Intralymphatic Allergen Immunotherapy
NCT05191186 ·Status: COMPLETED ·Phase: PHASE3
-
Standardization of Chortoglyphus Arcuatus Allergenic Extract. Determination of Biological Activity in HEP Units
NCT00718744 ·Status: COMPLETED ·Phase: PHASE2